Synairgen Plc (SNG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 06-2004 | |
| Sales | 82 |
| Cost of Goods | 18 |
| Gross Profit | 64 |
| Operating Expenses | 230 |
| Operating Income | -166 |
| Other Income | 13 |
| Pre-tax Income | -153 |
| Net Income Continuous | -153 |
| Net Income | $-153 |
| EPS Basic Total Ops | -0.01 |
| EPS Basic Continuous Ops | -0.01 |
| EPS Diluted Total Ops | -0.01 |
| EPS Diluted Continuous Ops | -0.01 |
| EBITDA(a) | $-164 |